Nitrogen and phosphorous are critical determinants of plant growth and productivity, and both plant growth and root morphology are important parameters for evaluating the effects of supplied nutrients. Previous work has shown that the growth of Acer mono seedlings is retarded under nursery conditions; we applied different levels of N (0, 5, 10, and 15 g plant-1) and P (0, 4, 6 and 8 g plant-1) fertilizer to investigate the effects of fertilization on the growth and root morphology of four-year-old seedlings in the field. Our results indicated that both N and P application significantly affected plant height, root collar diameter, chlorophyll content, and root morphology. Among the nutrient levels, 10 g N and 8 g P were found to yield maximum growth, and the maximum values of plant height, root collar diameter, chlorophyll content, and root morphology were obtained when 10 g N and 8 g P were used together. Therefore, the present study demonstrates that optimum levels of N and P can be used to improve seedling health and growth during the nursery period.
暂无摘要(点击查看原文获取完整内容)
暂无摘要(点击查看原文获取完整内容)
The hypothesis of a genetic control of plasma angiotensin I-converting enzyme (ACE) level has been suggested both by segregation analysis and by the identification of an insertion/deletion (I/D) polymorphism of the ACE gene, a polymorphism contributing much to the variability of ACE level. To elucidate whether the I/D polymorphism was directly involved in the genetic regulation, plasma ACE activity and genotype for the I/D polymorphism were both measured in a sample of 98 healthy nuclear families. The pattern of familial correlations of ACE level was compatible with a zero correlation between spouses and equal parent-offspring and sib-sib correlations (.24 +/- .04). A segregation analysis indicated that this familial resemblance could be entirely explained by the transmission of a codominant major gene. The I/D polymorphism was associated with marked differences of ACE levels, although these differences were less pronounced than those observed in the segregation analysis. After adjustment for the polymorphism effects, the residual heritability (.280 +/- .096) was significant. Finally, a combined segregation and linkage analysis provided evidence that the major-gene effect was due to a variant of the ACE gene, in strong linkage disequilibrium with the I/D polymorphism. The marker allele I appeared always associated with the major-gene allele s characterized by lower ACE levels. The frequency of allele I was .431 +/- .025, and that of major allele s was .557 +/- .041. The major gene had codominant effects equal to 1.3 residual SDs and accounted for 44% of the total variability of ACE level, as compared with 28% for the I/D polymorphism.(ABSTRACT TRUNCATED AT 250 WORDS)
UNLABELLED: There is a clear need for brief, but sensitive and specific, cognitive screening instruments as evidenced by the popularity of the Addenbrooke's Cognitive Examination (ACE). OBJECTIVES: We aimed to validate an improved revision (the ACE-R) which incorporates five sub-domain scores (orientation/attention, memory, verbal fluency, language and visuo-spatial). METHODS: Standard tests for evaluating dementia screening tests were applied. A total of 241 subjects participated in this study (Alzheimer's disease=67, frontotemporal dementia=55, dementia of Lewy Bodies=20; mild cognitive impairment-MCI=36; controls=63). RESULTS: Reliability of the ACE-R was very good (alpha coefficient=0.8). Correlation with the Clinical Dementia Scale was significant (r=-0.321, p<0.001). Two cut-offs were defined (88: sensitivity=0.94, specificity=0.89; 82: sensitivity=0.84, specificity=1.0). Likelihood ratios of dementia were generated for scores between 88 and 82: at a cut-off of 82 the likelihood of dementia is 100:1. A comparison of individual age and education matched groups of MCI, AD and controls placed the MCI group performance between controls and AD and revealed MCI patients to be impaired in areas other than memory (attention/orientation, verbal fluency and language). CONCLUSIONS: The ACE-R accomplishes standards of a valid dementia screening test, sensitive to early cognitive dysfunction.
暂无摘要(点击查看原文获取完整内容)
暂无摘要(点击查看原文获取完整内容)
<h3>Objective.</h3> —To evaluate the effect of angiotensin-converting enzyme (ACE) inhibitors on mortality and morbidity in patients with symptomatic congestive heart failure. <h3>Data Sources and Study Selection.</h3> —Data were obtained for all completed, published or unpublished, randomized, placebo-controlled trials of ACE inhibitors that were at least 8 weeks in duration and had determined total mortality by intention to treat, regardless of sample size. Trials were identified based on literature review and correspondence with investigators and pharmaceutical firms. <h3>Data Extraction.</h3> —Using standard tables, data were extracted by one author and confirmed where necessary by the other author or the principal investigator of the trial. Unpublished data were obtained by direct correspondence with the principal investigator of each study or pharmaceutical firm. <h3>Data Synthesis.</h3> —The data for each outcome were combined using the Yusuf-Peto adaptation of the Mantel-Haenszel method. Overall, there was a statistically significant reduction in total mortality (odds ratio [OR], 0.77; 95% confidence interval [CI], 0.67 to 0.88;<i>P</i><.001) and in the combined endpoint of mortality or hospitalization for congestive heart failure (OR, 0.65; 95% CI, 0.57 to 0.74;<i>P</i><.001). Similar benefits were observed with several different ACE inhibitors, although the data were largely based on enalapril maleate, captopril, ramipril, quinapril hydrochloride, and lisinopril. Reductions for total mortality and the combined endpoint were similar for various subgroups examined (age, sex, etiology, and New York Heart Association class). However, patients with the lowest ejection fraction appeared to have the greatest benefit. The greatest effect was seen during the first 3 months, but additional benefit was observed during further treatment. The reduction in mortality was primarily due to fewer deaths from progressive heart failure (OR, 0.69; 95% CI, 0.58 to 0.83); point estimates for effects on sudden or presumed arrhythmic deaths (OR, 0.91; 95% CI, 0.73 to 1.12) and fatal myocardial infarction (OR, 0.82; 95% CI, 0.60 to 1.11) were less than 1 but were not significant. <h3>Conclusions.</h3> —Total mortality and hospitalization for congestive heart failure are significantly reduced by ACE inhibitors with consistent effects in a broad range of patients. (<i>JAMA</i>. 1995;273:1450-1456)
Hourly averaged interplanetary magnetic field (IMF) and plasma data from the Advanced Composition Explorer (ACE) and Wind spacecraft, generated from 1 to 4 min resolution data time‐shifted to Earth have been analyzed for systematic and random differences. ACE moments‐based proton densities are larger than Wind/Solar Wind Experiment (SWE) fits‐based densities by up to 18%, depending on solar wind speed. ACE temperatures are less than Wind/SWE temperatures by up to ∼25%. ACE densities and temperatures were normalized to equivalent Wind values in National Space Science Data Center's creation of the OMNI 2 data set that contains 1963–2004 solar wind field and plasma data and other data. For times of ACE‐Wind transverse separations <60 R E , random differences between Wind values and normalized ACE values are ∼0.2 nT for ∣ B ∣, ∼0.45 nT for IMF Cartesian components, ∼5 km/s for flow speed, and ∼15 and ∼30% for proton densities and temperatures. These differences grow as a function of transverse separation more rapidly for IMF parameters than for plasma parameters. Autocorrelation analyses show that spatial scales become progressively shorter for the parameter sequence: flow speed, IMF magnitude, plasma density and temperature, IMF X and Y components, and IMF Z component. IMF variations have shorter scales at solar quiet times than at solar active times, while plasma variations show no equivalent solar cycle dependence.
BACKGROUND: Use of angiotensin-converting-enzyme (ACE) inhibitors during the second and third trimesters of pregnancy is contraindicated because of their association with an increased risk of fetopathy. In contrast, first-trimester use of ACE inhibitors has not been linked to adverse fetal outcomes. We conducted a study to assess the association between exposure to ACE inhibitors during the first trimester of pregnancy only and the risk of congenital malformations. METHODS: We studied a cohort of 29,507 infants enrolled in Tennessee Medicaid and born between 1985 and 2000 for whom there was no evidence of maternal diabetes. We identified 209 infants with exposure to ACE inhibitors in the first trimester alone, 202 infants with exposure to other antihypertensive medications in the first trimester alone, and 29,096 infants with no exposure to antihypertensive drugs at any time during gestation. Major congenital malformations were identified from linked vital records and hospitalization claims during the first year of life and confirmed by review of medical records. RESULTS: Infants with only first-trimester exposure to ACE inhibitors had an increased risk of major congenital malformations (risk ratio, 2.71; 95 percent confidence interval, 1.72 to 4.27) as compared with infants who had no exposure to antihypertensive medications. In contrast, fetal exposure to other antihypertensive medications during only the first trimester did not confer an increased risk (risk ratio, 0.66; 95 percent confidence interval, 0.25 to 1.75). Infants exposed to ACE inhibitors were at increased risk for malformations of the cardiovascular system (risk ratio, 3.72; 95 percent confidence interval, 1.89 to 7.30) and the central nervous system (risk ratio, 4.39; 95 percent confidence interval, 1.37 to 14.02). CONCLUSIONS: Exposure to ACE inhibitors during the first trimester cannot be considered safe and should be avoided.
SCISAT‐1, also known as the Atmospheric Chemistry Experiment (ACE), is a Canadian satellite mission for remote sensing of the Earth's atmosphere. It was launched into low Earth circular orbit (altitude 650 km, inclination 74°) on 12 Aug. 2003. The primary ACE instrument is a high spectral resolution (0.02 cm −1 ) Fourier Transform Spectrometer (FTS) operating from 2.2 to 13.3 μm (750–4400 cm −1 ). The satellite also features a dual spectrophotometer known as MAESTRO with wavelength coverage of 285–1030 nm and spectral resolution of 1–2 nm. A pair of filtered CMOS detector arrays records images of the Sun at 0.525 and 1.02 μm. Working primarily in solar occultation, the satellite provides altitude profile information (typically 10–100 km) for temperature, pressure, and the volume mixing ratios for several dozen molecules of atmospheric interest, as well as atmospheric extinction profiles over the latitudes 85°N to 85°S. This paper presents a mission overview and some of the first scientific results.
暂无摘要(点击查看原文获取完整内容)
暂无摘要(点击查看原文获取完整内容)
暂无摘要(点击查看原文获取完整内容)
The International Global Atmospheric Chemistry Program (IGAC) has conducted a series of Aerosol Characterization Experiments (ACE) that integrate in situ measurements, satellite observations, and models to reduce the uncertainty in calculations of the climate forcing due to aerosol particles. ACE‐Asia, the fourth in this series of experiments, consisted of two focused components: (1) An intensive field study that sought to quantify the spatial and vertical distribution of aerosol concentrations and properties, the processes controlling their formation, evolution, and fate, and the column‐integrated radiative effect of the aerosol (late March through May 2001). (2) A longer‐term network of ground stations that used in situ and column‐integrated measurements to quantify the chemical, physical, and optical properties of aerosols in the ACE‐Asia study area and to assess their spatial and temporal (seasonal and interannual) variability (2000–2003). The approach of the ACE‐Asia science team was to make simultaneous measurements of aerosol chemical, physical, and optical properties and their radiative impacts in a variety of air masses, often coordinated with satellite overpasses. Three aircraft, two research ships, a network of lidars, and many surface sites gathered data on Asian aerosols. Chemical transport models (CTMs) were integrated into the program from the start, being used in a forecast mode during the intensive observation period to identify promising areas for airborne and ship observations and then later as tools for integrating observations. The testing and improvement of a wide range of aerosol models (including microphysical, radiative transfer, CTM, and global climate models) was one important way in which we assessed our understanding of the properties and controlling processes of Asian aerosols. We describe here the scientific goals and objectives of the ACE‐Asia experiment, its observational strategies, the types of observations made by the mobile platforms and stationary sites, the models that will integrate our understanding of the climatic effect of aerosol particles, and the types of data that have been generated. Eight scientific questions focus the discussion. The intensive observations took place during a season of unusually heavy dust, so we have a large suite of observations of dust and its interaction with air pollutants. Further information about ACE‐Asia can be found on the project Web site at http://saga.pmel.noaa.gov/aceasia/ .
ACE 2, a novel homologue of angiotensin converting enzyme, has recently been identified. This study used QRT-PCR to quantitatively map the transcriptional expression profile of ACE 2 (and the two isoforms of ACE) in 72 human tissues. While confirming that ACE 2 expression is high in renal and cardiovascular tissues, the novel observation has been made that ACE 2 shows comparably high levels of expression in the gastrointestinal system, in particular in ileum, duodenum, jejunum, caecum and colon. Therefore, in probing the functional significance of this novel peptidase, some consideration should be given to a role in gastrointestinal physiology and pathophysiology.
暂无摘要(点击查看原文获取完整内容)
暂无摘要(点击查看原文获取完整内容)
<b>Smokers and those with COPD have increased airway expression of ACE-2, which is the entry receptor for the COVID-19 virus. This may explain the increased risk of severe COVID-19 in these subpopulations and highlight the importance of smoking cessation.</b>https://bit.ly/3bC29es
During the ACE-Asia field campaign, unprecedented amounts of aerosol property data in East Asia during springtime were collected from an array of aircraft, shipboard, and surface instruments. However, most of the observations were obtained in areas downwind of the source regions. In this paper, the newly developed satellite aerosol algorithm called "Deep Blue" was employed to characterize the properties of aerosols over source regions using radiance measurements from the Sea-viewing Wide Field-of-view Sensor (SeaWiFS) and Moderate Resolution Imaging Spectroradiometer (MODIS). Based upon the Aringngstroumlm exponent derived from the Deep Blue algorithm, it was demonstrated that this new algorithm is able to distinguish dust plumes from fine-mode pollution particles even in complex aerosol environments such as the one over Beijing. Furthermore, these results were validated by comparing them with observations from AERONET sites in China and Mongolia during spring 2001. These comparisons show that the values of satellite-retrieved aerosol optical thickness from Deep Blue are generally within 20%-30% of those measured by sunphotometers. The analyses also indicate that the roles of mineral dust and anthropogenic particles are comparable in contributing to the overall aerosol distributions during spring in northern China, while fine-mode particles are dominant over southern China. The spring season in East Asia consists of one of the most complex environments in terms of frequent cloudiness and wide ranges of aerosol loadings and types. This paper will discuss how the factors contributing to this complexity influence the resulting aerosol monthly averages from various satellite sensors and, thus, the synergy among satellite aerosol products